Randomized double-blind placebo-controlled study to evaluate the effect of long-acting mesalamine on postinfectious irritable bowel syndrome with diarrhea.
Ashok K TutejaDaniel T LeungJohn C FangNicholas J TalleyGregory J StoddardPublished in: Neurogastroenterology and motility (2024)
In patients with PI-IBS, long-acting mesalamine demonstrated to be effective in reducing IBS symptoms and improving QOL.